Understanding blood cell changes and heart health
Part of Blood & lymphatic, Heart & circulation clinical trials.
This study looks at how certain age-related changes in blood cells, called clonal hematopoiesis, affect inflammation and health. It aims to understand why some people with these changes develop heart problems or blood disorders, which could guide future prevention.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 60 or older.
- You have no history of stroke or heart attack, unless you join the specific heart group.
- You have not had any surgery in the last 3 months.
- You have no diagnosis of cancer (except certain blood disorders for some groups).
- You are not currently taking immunosuppressive medications like steroids, methotrexate, or biologics.
- You have no autoimmune or inflammatory diseases like rheumatoid arthritis or lupus.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how certain harmless changes in blood cells affect recovery after a first heart attack. It may help doctors understand why some people recover better than others.
This study collects blood samples and health information from people with certain unexplained blood cell changes or those at higher risk for them, to learn how these changes relate to inflammation and heart health.
This study follows adults who have certain blood-cell DNA changes (CHIP or CCUS) to learn how their condition may progress over time. It mainly looks at natural history—what happens in the blood without giving an active treatment.
This study looks at a condition called clonal hematopoiesis (CH), where some blood cells have changes that may affect their health. It aims to prevent, treat, and better understand CH. You may qualify if you are 55 or older and have low blood counts that persist over time.
This study follows people who may have early, unclear blood count problems or certain genetic/immune patterns that can later lead to bone marrow failure or blood cancers. It may help doctors better understand risks over time and guide earlier care.
This study looks at how blood-forming stem cells change in people with clonal hematopoiesis (CHIP), a common age-related blood condition. It may help researchers understand what these changes mean and who might be at higher risk for future blood problems.
Hear when a new Clonal Hematopoiesis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.